Virtual event

“Genome modification of immune cells”


Pharmaceutical

On September 20, 2022, Lonza will host a free virtual workshop on the use of genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned experts in genome editing from industry and academia and includes four interactive speaker sessions and a final panel discussion. The event is a chance for researchers to directly engage with leading voices in the field, catch up on the latest CRISPR research and applications, and learn tips and tricks for optimizing editing and CRISPR screening.

Interest in cell and gene therapies continues to grow, driven by their potential to treat the rarest and most complex human diseases. CRISPR technology has revolutionized this industry, providing a simple, precise and precise gene-editing tool to accelerate and scale discovery and development. Likewise, CRISPR opens up opportunities for optimized basic research and drug discovery in a range of other therapeutic areas. Bringing together a community of researchers who are at the forefront of the CRISPR revolution can help foster innovation, ultimately enabling more successful research and better treatments for patients.

“Immune Cell Genome Editing” – New Lonza Virtual Event. »

The event will bring together four internationally recognized experts in the field of genome editing, holding positions at respected global institutions such as the Berlin Center for Advanced Therapies and Stanford University. Lecturers have made important contributions to the field, including creating new methods for high-throughput genetic engineering of primary human immune cells and improving the intrinsic antitumor capacity of natural killer cells. In 25-minute sessions, experts will discuss:

• Generation of tumor-specific T cells using virus-free CRISPR gene editing

• Modification of the natural killer cell genome

• Best practices for setting up CRISPR displays, including how to find the optimal conditions for setting up networked CRISPR projections

• CRISPR phenotypic screening in iPSC-derived human macrophages as a platform for drug discovery

Each speaker session will be followed by a live Q&A session, and attendees will also be able to engage with the speakers during the final panel discussion. Prior to the event, registrants can submit questions that they would like experts to address during the workshop.

To register for the workshop, go to the event page.

See all the latest jobs in Pharmaceuticals